Heat Biologics Announces Planned Acquisition of Elusys Therapeutics
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Jeff Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Morrisville-based Heat Biologics has signed a definitive merger agreement to acquire Elusys Therapeutics, a biodefense company that makes a treatment for anthrax, a deadly infectious disease potentially spread by bioterrorism or biowarfare.
DURHAM - A biodefense company which already has an anti-anthrax product and has secured more than $350 million in federal contracts will soon become part of
La Crosse County Board continues search for police advisory study group
City councilors opted to wait until more information is available before acting on whether to extend the time period provided for the newly-formed city Ward Commission to complete its work